Pipeline Watch: Four Phase III Trial Starts And Four Approvals
Executive Summary
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
You may also be interested in...
Pipeline Watch: 11 New Approvals And 15 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Candel Therapeutics, Technoderma Medicines And More
Recent executive changes in the industry include C-suite moves at Bluebird Bio and Jounce Therapeutics. Meanwhile, new directors were appointed at Candel Therapeutics and Technoderma Medicines.
Pipeline Watch: Six New Approvals And 20 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.